Tuesday, 17 January 2017

FDA approves generic version of Jazz Pharma's sleep disorder drug

Jazz Pharma's shares were down 4.8 percent at $110 in extended trading.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)